September 21, 2014 10:49 PM ET

Healthcare Equipment and Supplies

Company Overview of Vibrynt, Inc.

Company Overview

Vibrynt, Inc. develops medical devices. It offers PREVAIL, a minimally invasive implant system for the treatment of morbid obesity. The company’s PREVAIL device assists patients suffering from obesity with weight loss by limiting food consumption. It serves customers in the United States, Australia, New Zealand, and Europe. The company was founded in 2006 and is based in Redwood City, California.

701 Galveston Drive

Redwood City, CA 94063

United States

Founded in 2006





Key Executives for Vibrynt, Inc.

Age: 54
Co-Founder and Vice President of Research & Development
Director of Operations
Vice President of Intellectual Property and General Counsel
Vice President of Regulatory
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Iogyn, Inc. United States
Artromick International, Inc. United States
Sarentis Therapeutics, Inc. United States
Immco Diagnostics, Inc. United States
Advanced Veterinary Technologies, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vibrynt, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at